Genmab Reduces Fair Value of Minnesota Manufacturing Facility to Zero, Moves Sale into 2013 and Updates 2012 Guidance
[at noodls] – Company Announcement Fair value of the manufacturing facility reduced to zero Non-cash impairment charge of DKK 331 million (USD 58 million) Sale now projected in Q1 2013, aggressive sales process proceeding … more
View todays social media effects on GENC
View the latest stocks trending across Twitter. Click to view dashboard